Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Patients with Acute Myeloid Leukemia in First Remission: A Study from the Global Committee and Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2024) 144 (Supplement 1): 2180.

https://doi.org/10.1182/blood-2024-200423

Published: 2024

Journal Articles

β2-Adrenergic Receptor Agonist Terbutaline Regulates Macrophage Polarization Via HMGB1 in Immune Thrombocytopenia

Qiuyu Guo, Ye-Jun Wu, Gao-Chao Zhang, Yu-Xiu Chen, Meng-Lin Li, Meng-Yu Xiao, Jian-Ying Zhou, Lu-Lu Wang, Meng-Tong Zang, Zhuo-Yu An, Hai-Xia Fu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2024) 144 (Supplement 1): 425.

https://doi.org/10.1182/blood-2024-203555

Published: 2024

Journal Articles

Real-World Effectiveness of Hetrombopag for Cancer Therapy-Induced Thrombocytopenia in Cancer Patients

Yuan Liu, Bo Liu, Runsheng Zhao, Shanshan Fang, Lin Li, Huixiong Qi, Quan Li

Blood (2024) 144 (Supplement 1): 5423.

https://doi.org/10.1182/blood-2024-202723

Published: 2024

Journal Articles

Bgb-16673, a Selective BTK Degrader, Exhibits Deeper Inhibition of Cancer Cell Signaling Pathways and Better Efficacy in MCL Models

Haitao Wang, Qiming Zhou, Lin Li, Weiwei Song, Shuang Peng, Xiangmei Chen, Linlin Xu, Teiko Sumiyoshi, Wei Jin, Zhirong Shen

Blood (2024) 144 (Supplement 1): 5833.

https://doi.org/10.1182/blood-2024-202909

Published: 2024

Journal Articles

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Fu Cheng Cheng, Song Jin, Junling Zhuang, Xin Zhou, Fan Zhou, Yuhua Li, Kaiyang Ding, Ting Niu, Wenming Chen, Baijun Fang, Li-Li Chen, Rong Fu, Hao Zhang, Jiaping Fu, Xiuju Wang, Sha Liu, Lin Li, Depei Wu

Blood (2024) 144 (Supplement 1): 6970.

https://doi.org/10.1182/blood-2024-204366

Published: 2024

Journal Articles

Monitoring the Signs and Symptoms of Variant Creutzfeldt-Jakob Disease Among Patients with Multiple Myeloma Treated with Ixazomib Capsules in China: A Real-World Pharmacovigilance Survey

Zhongjun Xia, Lin Li, Sha Liu

Blood (2024) 144 (Supplement 1): 6969.

https://doi.org/10.1182/blood-2024-202985

Published: 2024

Journal Articles

Similar Transplant Outcomes for Haplo and MUD Allo-Hcts in AML Patients Achieving CR2: A Study Analyzing 4030 Allo-HCT Recipients from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2024) 144 (Supplement 1): 3562.

https://doi.org/10.1182/blood-2024-200458

Published: 2024

Journal Articles

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Blood (2024) 143 (18): 1825–1836.

https://doi.org/10.1182/blood.2023019706

Published: 2024

Includes: Supplemental data

Journal Articles

Monitoring the Sign & Symptoms of Variant Creutzfeldt-Jakob Disease Among Patients with Multiple Myeloma Treated with Ixazomib Capsules in China: A Real-World Pharmacovigilance Survey

Zhongjun Xia, Xiaolin Xia, Lin Li, Sha Liu

Blood (2023) 142 (Supplement 1): 6629.

https://doi.org/10.1182/blood-2023-179108

Published: 2023

Journal Articles

A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2023) 142 (Supplement 1): 4986.

https://doi.org/10.1182/blood-2023-185685

Published: 2023

Journal Articles

Comparative Study for Haplo, MSD and MUD Allo-Hcts for AML Patients with KMT2A Rearrangement: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2023) 142 (Supplement 1): 660.

https://doi.org/10.1182/blood-2023-185557

Published: 2023

Journal Articles

Comparative Study for Haplo, MSD and MUD Allo-Hcts for Core-Binding Factor AML Patients in CR2: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2023) 142 (Supplement 1): 659.

https://doi.org/10.1182/blood-2023-186735

Published: 2023

Journal Articles

Treatment Patterns and Outcomes in Patients with Multiple Myeloma Who Received Ixazomib and in Patients with Triple-Class Refractory Multiple Myeloma: A Retrospective, Observational, Real-World Historical Database Analysis Study from China

Gang An, Lin Li, Sha Liu, Lugui Qiu

Blood (2023) 142 (Supplement 1): 6710.

https://doi.org/10.1182/blood-2023-182729

Published: 2023

Journal Articles

Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)

Chengcheng Fu, Xin Zhou, Junling Zhuang, Fan Zhou, Yuhua Li, Wenming Chen, Rong Fu, Baijun Fang, Ting Niu, Hao Zhang, Lin Li, Depei Wu

Blood (2022) 140 (Supplement 1): 12642–12644.

https://doi.org/10.1182/blood-2022-165127

Published: 2022

Journal Articles

Gut-Bile Acid-Immune Axis Regulates T Cell Homeostasis in the Pathogenesis of Immune Thrombocytopenia

Feng-Qi Liu, Qingyuan Qu, Yu-xiu Chen, Qi Chen, Meng-lin Li, Xueyan Sun, Hai-xia Fu, Kaiyan Liu, Xiao-hui Zhang

Blood (2022) 140 (Supplement 1): 8418–8419.

https://doi.org/10.1182/blood-2022-163458

Published: 2022

Journal Articles

Comparable Outcomes Following Non-First-Degree and First-Degree Related Donor Haploidentical Hematopoietic Cell Transplantation for Acute Leukemia Patients in Complete Remission: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Yishan Ye, Myriam Labopin, Jia Chen, Zafer Gulbas, Xi Zhang, Yener Koc, Didier Blaise, Fabio Ciceri, Emmanuelle Polge, Houhou Mohamad, Lin Li, Yi Luo, Depei Wu, He Huang, Mohamad Mohty, Norbert Claude Gorin, Sr.

Blood (2022) 140 (Supplement 1): 10603–10605.

https://doi.org/10.1182/blood-2022-158482

Published: 2022

Journal Articles

Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis

Qidi Chen, Min Xin, Lingjun Wang, Lin Li, Yingzhi Shen, Yan Geng, Haojie Jiang, Yang Wang, Lin Zhang, Yanyan Xu, Yu Hou, Junling Liu, Xuemei Fan

Blood (2022) 139 (19): 2958–2971.

https://doi.org/10.1182/blood.2022015620

Published: 2022

Includes: Supplemental data

Journal Articles

MRI-Derived Radiomics of Hemophilic Arthropathy Is Associated with Severity of Joint Disease

Bolin Song, Vidya Sankar Sankar Viswanathan, Jonathan Nutt, Lin Li, Navid Faraji, Christos Kosmas, Anant Madabhushi, Sanjay Ahuja

Blood (2021) 138 (Supplement 1): 2958.

https://doi.org/10.1182/blood-2021-151003

Published: 2021

Journal Articles

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139766

Published: 2020

Journal Articles

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-139623

Published: 2020

NARROW

Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Patients with Acute Myeloid Leukemia in First Remission: A Study from the Global Committee and Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

β2-Adrenergic Receptor Agonist Terbutaline Regulates Macrophage Polarization Via HMGB1 in Immune Thrombocytopenia

Real-World Effectiveness of Hetrombopag for Cancer Therapy-Induced Thrombocytopenia in Cancer Patients

Bgb-16673, a Selective BTK Degrader, Exhibits Deeper Inhibition of Cancer Cell Signaling Pathways and Better Efficacy in MCL Models

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Monitoring the Signs and Symptoms of Variant Creutzfeldt-Jakob Disease Among Patients with Multiple Myeloma Treated with Ixazomib Capsules in China: A Real-World Pharmacovigilance Survey

Similar Transplant Outcomes for Haplo and MUD Allo-Hcts in AML Patients Achieving CR2: A Study Analyzing 4030 Allo-HCT Recipients from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Monitoring the Sign & Symptoms of Variant Creutzfeldt-Jakob Disease Among Patients with Multiple Myeloma Treated with Ixazomib Capsules in China: A Real-World Pharmacovigilance Survey

A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Comparative Study for Haplo, MSD and MUD Allo-Hcts for AML Patients with KMT2A Rearrangement: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Comparative Study for Haplo, MSD and MUD Allo-Hcts for Core-Binding Factor AML Patients in CR2: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Treatment Patterns and Outcomes in Patients with Multiple Myeloma Who Received Ixazomib and in Patients with Triple-Class Refractory Multiple Myeloma: A Retrospective, Observational, Real-World Historical Database Analysis Study from China

Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)

Gut-Bile Acid-Immune Axis Regulates T Cell Homeostasis in the Pathogenesis of Immune Thrombocytopenia

Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis

MRI-Derived Radiomics of Hemophilic Arthropathy Is Associated with Severity of Joint Disease

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only